TickrTrends BMY fair value analysis

Bristol-Myers Squibb Stock: Is BMY Outperforming the Healthcare Sector?

finance.yahoo.com · 2026-09-03

Despite Bristol-Myers Squibb's outperformance relative to the healthcare sector over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Read the full story at finance.yahoo.com →

Is BMY undervalued? See TickrTrends' fair value analysis →